- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Nano Cap Stocks
Hong Kong Pharmaceuticals & Biotech Nano Cap Stocks
Results
5
Stocks with a market cap under US$50M.
5 companies
Austar Lifesciences
Market Cap: HK$369.1m
An investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.
6118
HK$0.72
7D
2.1%
1Y
-47.8%
Wai Yuen Tong Medicine Holdings
Market Cap: HK$345.5m
An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
897
HK$0.31
7D
8.8%
1Y
-3.1%
Uni-Bio Science Group
Market Cap: HK$340.4m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in Hong Kong, and People’s Republic of China.
690
HK$0.057
7D
-18.6%
1Y
-63.5%
Shenzhen Neptunus Interlong Bio-technique
Market Cap: HK$176.2m
Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.
8329
HK$0.10
7D
1.9%
1Y
-33.5%
Kontafarma China Holdings
Market Cap: HK$156.5m
An investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediates in Mainland China, Singapore, Taiwan, and internationally.
1312
HK$0.028
7D
-6.7%
1Y
-6.7%